TLR2 and neoplasm: Here, using human NSCLC samples and genetically engineered mouse models (GEMMs) of lung cancer, we demonstrate that TLR2 coordinates induction of cell-autonomous and non-cell-autonomous tumor suppressor responses that together impair NSCLC progression.